Selecting substances for treating glucocorticoid-mediated inflam

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 4, 435 71, 435 78, 435 79, 435 8, 435 15, 435366, 435371, 436501, 436503, 4241951, G01N 33566, C12Q 148, C12Q 166, C12N 500

Patent

active

058467424

ABSTRACT:
The present invention provides for the use of Tripterygium wilfordii Hook F extracts and purified components thereof in the treatment of inflammation or an immune disorder with concomitant lack of steroidal effect. Extracts of this plant (T2) bound to the glucocorticoid receptor and competitively inhibited glucocorticoid mediated cellular processes, such as dexamethasone binding to the glucocorticoid receptor, glucocorticoid mediated activation of target genes, dexamethasone dependent cellular growth, with concomitant inhibition of cyclooxygenase-2 induction and inflammatory processes such as the production of prostaglandin E.sub.2. The T2 extract components triptolide and tripdiolide were effective inhibitors. The particular advantage provided by the methods herein is the treatment or prevention of inflammation and the concomitant lack of steroidal agonist effects and NSAID side effects. Conditions treatable by the present methods include inflammation and immune disorders including autoimmune disease.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Selecting substances for treating glucocorticoid-mediated inflam does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selecting substances for treating glucocorticoid-mediated inflam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selecting substances for treating glucocorticoid-mediated inflam will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-175947

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.